Imaging of prostate cancer with positron emission tomography.


Journal

Clinical advances in hematology & oncology : H&O
ISSN: 1543-0790
Titre abrégé: Clin Adv Hematol Oncol
Pays: United States
ID NLM: 101167661

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 27 8 2019
pubmed: 27 8 2019
medline: 18 12 2019
Statut: ppublish

Résumé

Prostate cancer is most commonly imaged through a combination of magnetic resonance imaging, x-ray computed tomography, and

Identifiants

pubmed: 31449514

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-463

Auteurs

Michael E Zimmerman (ME)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Alexa R Meyer (AR)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Steven P Rowe (SP)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Michael A Gorin (MA)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH